Medicinal Products

Dáil Éireann Debate, Thursday - 14 January 2021

Thursday, 14 January 2021

Questions (234)

Catherine Connolly

Question:

234. Deputy Catherine Connolly asked the Minister for Health further to Parliamentary Question No. 333 of 16 December 2020, the status of the proposed reimbursement of Dupilumab for the treatment of atopic eczema; if the HSE drugs group January 2021 meeting has taken place to date; if so, if a decision on reimbursement was taken at the meeting; and if he will make a statement on the matter. [2128/21]

Written answers

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.